Rossari Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 429.05 | 369.28 | 337.07 |
| Operating Expense | 374.45 | 318.32 | 291.72 |
| Net Profit | 32.36 | 30.63 | 27.42 |
| Net Profit Margin | 7.54 | 8.29 | 8.13 |
| Earning Per Share | 5.85 | 5.53 | 4.96 |
| EBIDTA | 55.45 | 51.81 | 45.70 |
| Effective Tax Rate | 22.62 | 22.50 | 21.70 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 429.05 |
| Operating Expense | 374.45 |
| Net Profit | 32.36 |
| Net Profit Margin | 7.54 |
| Earning Per Share | 5.85 |
| EBIDTA | 55.45 |
| Effective Tax Rate | 22.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,431.63 | 1,202.91 | 975.17 |
| Operating Expenses Annual | 1,245.39 | 1,041.66 | 852.52 |
| Operating Profit Annual | 191.98 | 168.03 | 126.25 |
| Interest Annual | 9.58 | 9.70 | 4.62 |
| Depreciation | 22.89 | 20.76 | 24.27 |
| Net Profit Annual | 114.74 | 99.65 | 71.39 |
| Tax Annual | 39.96 | 34.49 | 24.26 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,431.63 |
| Operating Expenses Annual | 1,245.39 |
| Operating Profit Annual | 191.98 |
| Interest Annual | 9.58 |
| Depreciation | 22.89 |
| Net Profit Annual | 114.74 |
| Tax Annual | 39.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 22.55 | 40.50 | 26.74 |
| Cash Flow from Operations | 92.20 | 73.92 | 112.94 |
| Cash Flow from Investing | -69.57 | -69.78 | -160.39 |
| Cash Flow from Financing | -32.27 | -22.09 | 61.21 |
| Cash Flow at the End | 12.91 | 22.55 | 40.50 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 22.55 |
| Cash Flow from Operations | 92.20 |
| Cash Flow from Investing | -69.57 |
| Cash Flow from Financing | -32.27 |
| Cash Flow at the End | 12.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 13.41 | 13.97 | 12.95 |
| PBIT Margin (%) | 11.48 | 11.96 | 10.28 |
| PBT Margin (%) | 10.28 | 10.73 | 8.05 |
| Net PROFIT Margin (%) | 8.01 | 8.28 | 7.32 |
| Return On Networth / Equity (%) | 11.26 | 10.96 | 8.69 |
| Return On Networth /Employed (%) | 15.21 | 14.71 | 11.72 |
| Return On Assets (%) | 10.66 | 10.19 | 8.35 |
| Total Debt / Equity (X) | 0.06 | 0.07 | 0.04 |
| Asset Turnover Ratio (%) | 1.33 | 1.23 | 1.14 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 13.41 |
| PBIT Margin (%) | 11.48 |
| PBT Margin (%) | 10.28 |
| Net PROFIT Margin (%) | 8.01 |
| Return On Networth / Equity (%) | 11.26 |
| Return On Networth /Employed (%) | 15.21 |
| Return On Assets (%) | 10.66 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 1.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 179.20 | 167.29 | 160.07 |
| Total Current Assets Annual | 696.95 | 566.77 | 469.73 |
| Non Current Assets Annual | 752.76 | 713.19 | 654.73 |
| Total Shareholders Funds Annual | 1,077.17 | 960.34 | 858.70 |
| Total Assets Annual | 1,450.92 | 1,281.17 | 1,125.67 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 179.20 |
| Total Current Assets Annual | 696.95 |
| Non Current Assets Annual | 752.76 |
| Total Shareholders Funds Annual | 1,077.17 |
| Total Assets Annual | 1,450.92 |
EPS (INR)
Expected
6.22
Reported
6.22
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
